Direct visual inspection of the cervix with Lugol iodine for the detection of premalignant lesions

Journal of Lower Genital Tract Disease

Volumn 12, Issue 3, 2008, Pages 193-198

  El Shalakany, Amr H ^a,b   Saeed, Mohammed M ^a   Reda Abdel Aal, Mohammed ^a   El Nakeeb, Atef Hamed ^a   Noseirat, Nael ^a   Ayyad, Sohair B ^a   El Din, Zeinab Sehab ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Cervix; Inspection; Iodine; Visual

Indexed keywords

ACETIC ACID; LUGOL; COLORING AGENT; DIAGNOSTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; IODIDE; LUGOL'S SOLUTION;

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRECANCER; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX DYSPLASIA; VAGINA SMEAR;

ACETIC ACID; ADULT; AGED; AGED, 80 AND OVER; COLORING AGENTS; COLPOSCOPY; FEMALE; HUMANS; INDICATORS AND REAGENTS; IODIDES; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS;

EID: 50549087271     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31815f527c     Document Type: Article

References (29)

1. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-56.
2. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001;79:954-62.
3. Gaffikin L, Blumenthal PD, McGrath J, Chirenje ZM. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Lancet 1999;353:869-73.
4. Denny L, Kuhn L, Pollack A, Wainwright H, Wright TC, Jr. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000;89:826-33.
5. Denny L, Kuhn L, Pollack A, Wright TC, Jr. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002;94: 1699-707.
6. Cronje HS, Parham GP, Cooreman BF, de Beer A, Divall P, Bam RH. A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol 2003;188:395-400.
7. Ghaemmaghami F, Behtash N, Modares Gilani M, Mousavi A, Marjani M, Moghimi R. Visual inspection with acetic acid as a feasible screening test for cervical neoplasia in Iran. Int J Gynecol Cancer 2004;14:465-9.
8. El-Shalakany A, Hassan SS, Ammar E, Ibrahim MA, Salam MA, Farid M. Direct visual inspection of the cervix for the detection of premalignant lesions. J Low Genit Tract Dis 2004;8:16-20.
9. De Vuyst H, Claeys P, Njiru S, Muchiri L, Steyaert S, De Sutter P, et al. Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA-PCR testing and cervicography. Int J Gynecol Obstet 2005;89: 120-6.
10. Doh AS, Nkele NN, Achu P, Essimbi F, Essame O, Nkegoum B. Visual inspection with acetic acid and cytology as screening methods for cervical lesions in Cameroon. Int J Gynecol Obstet 2005;89:167-73.
11. Belinson JL, Pretorius RG, Zhang WH, Wu LY, Qiao YL, Elson P. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 2001;98:441-4.
12. Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer 2004;110:907-13.
13. Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P, et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer 2003;106:404-8.
14. Shastri SS, Dinshaw K, Amin G, Goswami S, Patil S, Chinoy R, et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ 2005;83:186-94.
15. Stafl A, Friedrich EG Jr., Mattingly RF. Detection of Cervical Neoplasia: Reducing the Risk of Error. CA Cancer J Clin 1974;24:22-30.
16. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
17. Walker P, Dexeus S, De Palo G, Barrasso R, Campion M, Girardi F, et al. International Terminology of Colposcopy: An Updated Report From the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 2003; 101:175-7.
18. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intra-epithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-400.
19. Alvarez RD, Wright TC. Effective cervical neoplasia detection with a novel optical detection system: a randomized trial. Gynecol Oncol 2007;104:281-9.
20. Chute DJ, Covell J, Pambuccian SE, Stelow EB. Cytologic-histologic correlation of screening and diagnostic Papanicolaou tests. Diagn Cytopathol 2006;34:503-6.
21. Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Garcia S, et al. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision procedure: follow-up and value of human papillomavirus testing. Am J Obstet Gynecol 2007;197:359.e1-6.
22. Slawson D, Bennett J, Herman J. Are Papanicolaou smears enough? Acetic acid washes of the cervix as adjunctive therapy: a HARNET study. J Family Practice 1992;35:271-7.
23. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.
24. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132: 810-9.
25. Li N, Ma CP, Sun LX, Zhang YZ, Shao SL, Xing JX, et al. Evaluation on the visual inspection with Lugol's iodine in cervical cancer screening program [abstract in English]. Zhonghua Liu Xing Bing Xue Za Zhi 2006;27:15-8.
26. Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin American Screening) study. J Med Screen 2005;12:142-9.
27. Sangwa-Lugoma G, Mahmud S, Nasr SH, Liaras J, Kayembe PK, Tozin RR, et al. Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer 2006;119:1389-95.
28. Ngelangel CA, Limson GM, Cordero CP, Abelardo AD, Avila JM, Festin MR and UP-DOH CCSHOSG. Acetic-acid guided visual inspection vs. cytology-based screening for cervical cancer in the Philippines. Int J Gynaecol Obstet 2003; 83:141-50.
29. Bhatla N, Mukhopadhyay A, Joshi S, Kumar A, Kriplani A, Pandey RM, et al. Visual inspection for cervical cancer screening: evaluation by doctor versus paramedical worker. Indian J Cancer 2004;41:32-6.